Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings Dec 9, 2025 08:15AM
Nuwellis adds pediatric hospital client for Aquadex therapy Dec 4, 2025 08:17AM
Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. Dec 4, 2025 08:15AM
Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum Nov 12, 2025 08:15AM
Nuwellis receives patent allowance for pediatric blood filtration safety tech Nov 10, 2025 09:00AM
View Older Stories

Nov 10, 2025 09:00AM Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian™ Pediatric System with Advanced Clamp Safety Technology
Oct 23, 2025 09:00AM Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025
Sep 30, 2025 08:47AM Nuwellis reports 92% survival rate in pediatric kidney treatment study
Sep 30, 2025 08:45AM Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex®
Sep 18, 2025 09:03AM Nuwellis receives US patent for hemolysis sensing in pediatric device
Sep 18, 2025 09:00AM Nuwellis Receives New US Patent Reinforcing Vivian™ Pediatric Device Focused on Safer, More Precise Ultrafiltration
Sep 17, 2025 10:16AM Nuwellis, Inc. Participates in a Virtual Investor “What This Means” Segment
Sep 9, 2025 09:02AM Nuwellis receives $3 million NIH grant for pediatric kidney device
Sep 9, 2025 09:00AM Nuwellis’ Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio
Sep 4, 2025 08:15AM Nuwellis plans 24-hour Aquadex circuit for outpatient fluid therapy
Sep 4, 2025 08:15AM Nuwellis Introduces New 24-Hour Aquadex™ Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management
Aug 21, 2025 08:15AM Nuwellis gets FDA clearance for new catheter length
Aug 21, 2025 08:15AM Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter
Aug 19, 2025 08:15AM Nuwellis signs letter of intent to acquire Rendiatech monitoring firm
Aug 19, 2025 08:15AM Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company
Aug 15, 2025 08:15AM Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Aug 7, 2025 08:15AM Nuwellis exits international operations to focus on U.S. market
Aug 7, 2025 08:15AM Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus
Aug 6, 2025 08:15AM Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025
Aug 5, 2025 08:15AM Nuwellis treats first patients with outpatient ultrafiltration therapy
Aug 5, 2025 08:15AM Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow® System Under New CMS Code
Aug 4, 2025 05:25PM Nuwellis stockholders approve warrant exercise and share increase proposals
Aug 4, 2025 05:24PM Nuwellis Stockholders Approve All Proposals at Special Meeting
Jul 23, 2025 08:45AM Nuwellis Participates in the Virtual Investor “What’s Your Story” Summer Spotlight On-Demand Conference
Jul 23, 2025 08:15AM Nuwellis regains compliance with NASDAQ minimum bid price requirement
Jul 23, 2025 08:15AM Nuwellis Regains Compliance with Nasdaq Listing Requirements
Jul 17, 2025 07:35AM Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care
Jul 15, 2025 04:05PM Nuwellis receives US patent for blood filtering system improvements
Jul 15, 2025 04:05PM Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation
Jul 2, 2025 08:15AM Nuwellis (NUWE) Appoints John Erb as CEO
Jul 2, 2025 08:15AM Nuwellis Appoints John Erb as Chief Executive Officer
May 12, 2025 07:03AM Nuwellis (NUWE) Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency
May 12, 2025 07:00AM Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency
May 8, 2025 07:00AM Nuwellis Expands Aquadex® for Pediatric Fluid Management to Two New Hospital Systems
Apr 24, 2025 07:00AM Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
Dec 19, 2024 09:02AM Nuwellis (NUWE) Regains Nasdaq Compliance
Dec 19, 2024 09:00AM Nuwellis Regains Compliance with Nasdaq Listing Requirements
Nov 5, 2024 09:28AM Nuwellis (NUWE) Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Nov 5, 2024 09:28AM Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Nov 4, 2024 08:32AM Nuwellis (NUWE) Receives Increased Reimbursement Rate for Aquadex SmartFlow Therapy from the Centers for Medicare and Medicaid
Nov 4, 2024 08:30AM Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow® Therapy from the Centers for Medicare and Medicaid
Jun 26, 2024 08:45AM Nuwellis (NUWE) Announces Reverse Stock Split
Jun 26, 2024 08:45AM Nuwellis Announces Reverse Stock Split
Jun 25, 2024 09:00AM Nuwellis Secures New Patent for Innovative Pediatric Continuous Renal Replacement Therapy, Vivian™
May 14, 2024 09:00AM Nuwellis Announces Expansion of Ultrafiltration Program to Pediatric Patients at One of the Largest Hospital Networks in Florida
May 2, 2024 09:03AM Nuwellis (NUWE) Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
May 2, 2024 09:00AM Nuwellis Receives USPTO Notice of Patent Allowance for Innovative Pediatric CRRT Technology
Jan 4, 2024 03:05PM Nuwellis (NUWE) Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
Jan 4, 2024 03:05PM Nuwellis Receives FDA Clearance for an Additional Dual Lumen Extended Length Peripheral Catheter
Nov 28, 2023 08:09AM Nuwellis (NUWE) Announces New Real-World Data Highlight the Clinical Benefits of Ultrafiltration Therapy with Hematocrit Monitoring for Pediatric Patients
View Older Stories